Developing best-in-disease drugs for osteoarthritis pain and disease modification

1. Managing a portfolio of investments in NASDAQ-traded biopharma companies in the US and EU on behalf of global clients.2. Investment based on fundamental analysis of the value of new drugs in development.3. Strong expertise in pharmaceutical development strategies in the US.4. Deep experience in biopharma finance and valuation.

1. Conducted research in regenerative medicine and tissue engineering in Dr. Gordana Vunjak-Novakovic's lab. 2. Focused on the role of cartilage extracellular matrix in the regulation of cartilage homeostasis. 3. Discovered novel biomaterials that promote cartilage regeneration4. Other projects included bone tissue engineering and the application of biomaterials in osteochondral research and drug development in musculoskeletal diseases

1. Conducted due diligence on medical device companies, including product competitiveness, market dynamics, regulatory environment, and financial conditions.2. Prepared investor presentations and financial forecasts for fundraising.

Conducted research in Dr. Steve Blacklow's lab on structural biology of Notch proteins.

Conducted research in Dr. Stuart Orkin's lab on transcriptional signaling network in embryonic stem cells.